RC

Rowan Chapman

Non Executive Director at Cambridge Innovation Capital

San Francisco Bay Area

Overview

Work Experience

  • Co-Founder

    2023 - Current

    Investing in early stage companies at the intersection of science, engineering, and computation.

  • Board Member

    2023

    Building a completely new way to quickly structure, standardize, and clean healthcare and clinical data using AI.

  • Non Executive Director

    2022

    A leading venture investor in Cambridge backing and building category-leading deep tech and life sciences companies.

  • Board Member

    2021

    An automated platform to enable a richer understanding of individual cell behaviors, interactions, and functions across a range of stimuli and parameters, at massively parallel scale.

  • Board Member (NTRA)

    2019

    Committees: Chair Compensation, Member Audit Natera® is a worldwide genetic testing and diagnostics company that’s changing how doctors and patients manage genetic disease. Our team includes clinicians, scientists, biostatisticians, researchers, and talented laboratory professionals from around the globe.

  • Co-Founder, Advisor

    2020

    Initiate partners with entrepreneurs to launch innovative companies built on bold ideas. We focus at the intersections of healthcare, life sciences and technology. Founder success is our success.

  • Board Member

    2014 - 2024

    Independent board member Committees: Chair Compensation, Member Audit Evidation Health seeks to improve health outcomes through clinically and economically beneficial digital health solutions and new approaches to predictive analytics.

  • Senior VP, Head of Innovation, Western North America, Australia & New Zealand

    2017 - 2019

    Led the J&J California team responsible for entrepreneurial ecosystem collaborations, deals and investments across Pharmaceutical, Medical Device and Consumer sectors. Drove deal structures including co-development, licensing, sponsored research and investment with negotiated terms ranging to >$1B.

  • Board Member

    2015 - 2018

    Initially CEO, then board member. Acquired by Thorne (THRN) Drawbridge Health is focused on enabling personal diagnostic testing – anytime, anywhere with a people-friendly system for collecting and stabilizing blood samples

  • Global Head of Healthcare Investing

    2015 - 2017

    Managed team responsible for GE Ventures’ healthcare investing strategy, portfolio, venture partnerships and thought leadership. Oversaw creation of three new businesses, managed portfolio of >20 healthcare investments plus LP positions and portfolio company partnering. Member of GE Ventures investing committee, reviewing and approving investments and partnerships across GE verticals (energy, connected environments, iOT/digital, healthcare, advanced manufacturing).

  • Managing Director Healthcare Business Creation

    2014 - 2015

    Created new businesses for GE at intersection of data, consumer and healthcare. Internal entrepreneur forming companies as interim CEO from ground up - coordinating market analysis, business and operating plan, internal/external asset and IP negotiation, setting up structure and governance, financing, hiring and partnering strategy.

Relevant Websites